Services

SterPath provides strategic and technical advisory across drug product development, delivery platforms, and early CMC, supporting programs at the interface of discovery and early development. Services are designed to align formulation, delivery, and manufacturing considerations with target product profiles from the outset, enabling informed decision-making and reducing downstream development risk.

Engagements are tailored to the specific needs of each program, ranging from focused advisory support to broader involvement in technology evaluation and development planning. The objective is to enable efficient transition from discovery to development while establishing robust, scalable, and clinically viable product strategies.

Early CMC Strategy

Development of early-stage CMC strategies aligned with target product profiles, focusing on risk mitigation, manufacturability, and long-term development efficiency.

Drug Product Development

Advisory support across formulation design, process considerations, and early development of complex therapeutic modalities, including biologics and advanced delivery systems.

Delivery Platform Evaluation

Assessment and selection of delivery technologies, including lipid nanoparticles and emerging platforms, ensuring alignment with product requirements and development strategy.

Discovery to Development Transition

Structured support in bridging research and development, enabling informed decision-making and scalable development pathways.

Design based on Editorial by HTML5 UP --- Images sourced from Unsplash